Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Myseum (MYSE) EBITDA (2021 - 2025)

Historic EBITDA for Myseum (MYSE) over the last 5 years, with Q3 2025 value amounting to -$1.2 million.

  • Myseum's EBITDA fell 405.79% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.3 million, marking a year-over-year increase of 151.56%. This contributed to the annual value of -$5.0 million for FY2024, which is 4012.2% up from last year.
  • Myseum's EBITDA amounted to -$1.2 million in Q3 2025, which was down 405.79% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, Myseum's EBITDA ranged from a high of -$645927.0 in Q2 2021 and a low of -$7.3 million during Q4 2021
  • Moreover, its 5-year median value for EBITDA was -$1.6 million (2025), whereas its average is -$2.1 million.
  • Its EBITDA has fluctuated over the past 5 years, first tumbled by 29969.1% in 2022, then skyrocketed by 5958.71% in 2023.
  • Quarter analysis of 5 years shows Myseum's EBITDA stood at -$7.3 million in 2021, then skyrocketed by 51.88% to -$3.5 million in 2022, then skyrocketed by 59.59% to -$1.4 million in 2023, then rose by 24.69% to -$1.1 million in 2024, then decreased by 14.49% to -$1.2 million in 2025.
  • Its EBITDA stands at -$1.2 million for Q3 2025, versus -$1.4 million for Q2 2025 and -$1.6 million for Q1 2025.